Complete mandatory preoperative workup including MRI/CT pelvis, biopsy confirmation, physical therapy assessment, nutritional optimization, 8-hour fasting, bowel preparation, prophylactic antibiotics, and thromboembolic prophylaxis.
Transfer to ICU/HDU for hemodynamic monitoring. Strict bed rest for initial 24-48 hours, followed by progressive mobilization with physical therapy. Pain management via multimodal analgesia. Wound care, DVT prophylaxis, and monitoring for neurovascular deficit. Discharge criteria include stable pain control, independent mobilization capability, and wound healing progress.
Comprehensive Clinical Guide: Type III Pelvic Resection (Ischium/Pubis)
1. Introduction and Clinical Overview
A Type III Pelvic Resection, specifically targeting the ischium and pubis (the anterior and inferior components of the pelvic ring), represents one of the most challenging orthopedic oncology procedures. Defined by the Enneking and Dunham classification system, a Type III resection involves the removal of the anterior pelvic segment. This region is anatomically complex, serving as a critical anchor point for the hip adductor muscles, the pelvic floor, and the urogenital apparatus.
The primary objective of this procedure is achieving wide surgical margins in the presence of primary malignant bone tumors (e.g., chondrosarcoma, osteosarcoma, Ewing sarcoma) or aggressive locally recurrent benign tumors. Because the pelvic ring provides structural stability and serves as a conduit for critical neurovascular structures (the obturator nerve, femoral vessels, and pelvic viscera), resection requires meticulous anatomical dissection and, frequently, advanced reconstructive strategies to restore functional integrity.
2. Deep-Dive: Technical Specifications and Mechanisms
The Enneking classification divides the pelvis into three zones:
* Type I: Ilium.
* Type II: Periacetabular region.
* Type III: Ischium and Pubis.
Anatomical Considerations
The Type III resection necessitates the removal of the pubic rami and the ischial tuberosity. The surgical challenge lies in the "medial" aspect of the pelvic ring. The bladder, urethra, and rectum are in direct proximity to the medial surface of the pubis and ischium. Damage to these structures is a primary concern during the subperiosteal or extra-periosteal dissection.
Biomechanical Impact
The removal of the ischium and pubis disrupts the origin of the adductor muscle group (adductor longus, brevis, and magnus). Furthermore, the integrity of the pelvic ring is compromised. If the resection extends near the acetabulum, weight-bearing kinematics are significantly altered. Surgeons must assess whether the remaining pelvic ring can sustain physiological loads or if internal fixation/allograft reconstruction is required.
3. Extensive Clinical Indications and Usage
The decision to perform a Type III resection is driven by the oncological necessity to achieve an R0 (negative margin) resection.
Primary Indications
| Condition | Clinical Context |
|---|---|
| Chondrosarcoma | Often low-grade but locally aggressive; requires wide margins. |
| Osteosarcoma | High-grade malignancy; requires wide margins and adjuvant chemotherapy. |
| Ewing Sarcoma | Highly sensitive to chemotherapy; surgery used for residual disease. |
| Metastatic Disease | Palliative intent for intractable pain or impending pathological fracture. |
| Aggressive Fibromatosis | Desmoid tumors that threaten neurovascular bundles. |
Diagnostic Workup
- Imaging: High-resolution MRI (with gadolinium) is the gold standard for soft tissue extension. CT scans are essential for assessing bone destruction and planning reconstructive hardware.
- Biopsy: Must be performed by the treating orthopedic oncologist to ensure the biopsy tract can be excised during the definitive surgery.
- Vascular Mapping: Angiography or CT angiography is mandatory to visualize the relationship between the tumor and the external iliac/obturator vessels.
4. Procedure: Surgical Steps
The procedure is highly specialized and generally follows a multidisciplinary approach involving orthopedics, urology, and vascular surgery.
Phase I: Positioning and Exposure
- Positioning: Typically lateral or supine, depending on the extent of the pubic involvement.
- Incision: A modified ilioinguinal or Smith-Petersen approach is standard. The incision may be extended medially to facilitate access to the symphysis pubis.
Phase II: Dissection and Osteotomy
- Vascular Control: Identification and mobilization of the femoral vessels and the obturator neurovascular bundle.
- Soft Tissue Release: Detachment of the abdominal wall musculature and the adductor group from the pubic rami.
- Osteotomy: Using an oscillating saw or Gigli saw, the osteotomies are performed at the planned margins—typically at the superior pubic ramus and the ischium near the acetabulum.
Phase III: Reconstruction
- Stability: If the pelvic ring integrity is compromised, reconstruction may involve a reconstruction plate or a custom 3D-printed titanium implant.
- Soft Tissue Coverage: Often requires a rotational flap (e.g., rectus abdominis or vertical rectus abdominis myocutaneous flap) to fill the dead space and provide vascularized tissue coverage for the bladder and rectum.
5. Post-Operative Recovery and Protocol
Recovery from a Type III resection is a protracted process requiring a dedicated rehabilitation team.
Immediate Post-Op (Days 1–7)
- Mobilization: Non-weight-bearing (NWB) on the affected side for 6–12 weeks.
- Bladder Management: Foley catheter maintenance is critical, as the bladder base is often manipulated.
- DVT Prophylaxis: Aggressive anticoagulation is required due to the pelvic dissection and immobilization.
Long-Term Rehabilitation
- Physical Therapy: Focus on gentle isometric strengthening of the pelvic floor and hip stabilizers.
- Gait Training: Progressive loading protocols based on radiographic evidence of healing or implant integration.
6. Risks, Side Effects, and Contraindications
Potential Complications
- Neurovascular Injury: Injury to the obturator or femoral nerve resulting in motor/sensory deficits.
- Urological Dysfunction: Urinary retention, incontinence, or bladder injury requiring long-term catheterization.
- Wound Complications: High risk of dehiscence or infection due to the proximity to the perineal region.
- Hardware Failure: Fatigue failure of plates if the patient fails to adhere to weight-bearing restrictions.
Contraindications
- Systemic Metastasis: Where surgery offers no survival benefit.
- Vascular Encasement: Unresectable involvement of the external iliac or femoral vessels.
- Infection: Active sepsis or severe local skin infection at the site of the planned incision.
7. Alternative Treatments
When a Type III resection is deemed too morbid or when margins cannot be achieved, alternatives include:
1. Definitive Radiotherapy: Proton beam therapy or carbon-ion radiotherapy for unresectable sarcomas.
2. Chemotherapy (Neoadjuvant): To downstage the tumor, potentially allowing for a less invasive resection.
3. Embolization: For palliative management of highly vascularized tumors (e.g., giant cell tumors).
8. Massive FAQ Section
1. How long is the surgery for a Type III Pelvic Resection?
Typically 6 to 10 hours, depending on the complexity of the reconstruction and the involvement of vascular/urological specialists.
2. Will I need a colostomy or urostomy?
Rarely. While the bladder and rectum are adjacent, they are typically preserved. However, if the tumor involves these organs, a temporary diversion may be necessary.
3. What is the success rate of this procedure?
Success is measured by local control. In specialized centers, local recurrence rates for primary bone sarcomas are under 20% with wide margins.
4. How long do I stay in the hospital?
Average length of stay is 7 to 14 days, assuming no post-operative wound complications.
5. Will I walk normally again?
Most patients regain a functional gait, though some may require a cane or experience a slight limp due to the loss of adductor muscle attachments.
6. What is the biggest risk?
Wound healing complications and deep infection are the most frequent challenges, given the anatomical location and potential for contamination.
7. Can 3D printing help?
Yes. 3D-printed titanium implants are increasingly used to bridge the bony gap, providing better structural stability than traditional plates.
8. What happens to the muscles removed?
The adductor muscles are typically reattached to the remaining pelvis or the reconstruction hardware, but some loss of power in the hip adduction is expected.
9. Is this procedure done for benign tumors?
Yes, but only for aggressive or recurrent benign tumors (e.g., aggressive giant cell tumors) that threaten the integrity of the pelvic ring.
10. How is pain managed post-operatively?
A multimodal approach is used, including epidural anesthesia for the first 48–72 hours, followed by intravenous or oral analgesics and nerve blocks.
9. Conclusion
The Type III Pelvic Resection (Ischium/Pubis) is a high-stakes, technically demanding procedure that sits at the intersection of orthopedic oncology and reconstructive surgery. Success depends heavily on pre-operative planning, precise surgical execution, and a multidisciplinary approach to post-operative care. By adhering to strict oncological margin protocols and utilizing advanced reconstructive technologies, surgeons can provide patients with optimal functional outcomes despite the severity of their diagnosis.
Disclaimer: This guide is for educational purposes for medical professionals. Clinical decisions must always be tailored to the individual patient’s pathology, performance status, and institutional capabilities.